{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:15:51Z","timestamp":1784632551766,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Research Foundation of South Africa"},{"name":"University of KwaZulu-Natal College of Health Sciences"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbr.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T05:43:35Z","timestamp":1473399815000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression"],"prefix":"10.1016","volume":"316","author":[{"given":"Ernest","family":"Dall\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie M.U.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4994-1322","authenticated-orcid":false,"given":"Musa V.","family":"Mabandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.08.005_bib0005","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1023\/B:MEBR.0000027412.19664.b3","article-title":"Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor","volume":"19","author":"Daniels","year":"2004","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2016.08.005_bib0010","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0015","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.expneurol.2011.09.035","article-title":"Stress: depression and Parkinson's disease","volume":"233","author":"Hemmerle","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0020","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.08.005_bib0025","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2016.08.005_bib0030","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson's disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bbr.2016.08.005_bib0035","first-page":"401264","article-title":"Oxidative stress and microglial cells in Parkinson's disease","author":"Peterson","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbr.2016.08.005_bib0040","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2015.10.006","article-title":"Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease","volume":"26","author":"Olson","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0045","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1186\/1742-2094-8-9","article-title":"CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson\u2019s disease","volume":"8","author":"Pabon","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbr.2016.08.005_bib0050","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","article-title":"Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression","volume":"225","author":"You","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"Suppl","key":"10.1016\/j.bbr.2016.08.005_bib0055","first-page":"143","article-title":"Cytokines in Parkinson's disease","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2016.08.005_bib0060","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.nucmedbio.2012.04.001","article-title":"Acute treatment with fluvoxamine elevates rat brain serotonin synthesis in some terminal regions: an autoradiographic study","volume":"39","author":"Muck-Seler","year":"2012","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0065","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006114.pub2","article-title":"Fluvoxamine versus other anti-depressive agents for depression","author":"Omori","year":"2010","journal-title":"Cochr. Database Syst. Rev."},{"key":"10.1016\/j.bbr.2016.08.005_bib0070","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/jnr.21899","article-title":"Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect","volume":"87","author":"Lim","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0075","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","article-title":"Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease","volume":"185","author":"Chung","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0080","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.bbr.2014.08.014","article-title":"Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of Parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine","volume":"274","author":"Barbiero","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0085","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2016.08.005_bib0090","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1148\/radiol.2272012051","article-title":"Sample size estimation: how many individuals should be studied?","volume":"227","author":"Eng","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.bbr.2016.08.005_bib0095","first-page":"7","article-title":"Exposure to early life stress results in epigenetic changes in neurotrophic factor gene expression in a Parkinsonian rat model","volume":"2016","author":"Mpofana","year":"2016","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.bbr.2016.08.005_bib0100","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijdevneu.2016.06.004","article-title":"Anti-parkinsonian effects of fluvoxamine maleate in maternally separated rats","volume":"53","author":"Dalle","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.005_bib0105","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbr.2010.02.045","article-title":"Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats","volume":"211","author":"Mabandla","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0110","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbr.2009.11.005","article-title":"Long-term postpartum anxiety and depression-like behavior in mother rats subjected to maternal separation are ameliorated by palatable high fat diet","volume":"208","author":"Maniam","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0115","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4236\/jbbs.2014.42011","article-title":"Neuroprotective effects of caffeine on a maternally separated Parkinsonian rat model","volume":"4","author":"Mpofana","year":"2014","journal-title":"J. Behav. Brain Sci."},{"key":"10.1016\/j.bbr.2016.08.005_bib0120","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.005_bib0125","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuroscience.2015.05.030","article-title":"The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease","volume":"300","author":"Santiago","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2016.08.005_bib0130","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.21-12-04427.2001","article-title":"Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine","volume":"21","author":"Tillerson","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.005_bib0135","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00213-003-1430-1","article-title":"Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients","volume":"167","author":"Gerstenberg","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2016.08.005_bib0140","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archpsyc.1990.01810180077011","article-title":"Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine","volume":"47","author":"Goodman","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbr.2016.08.005_bib0145","series-title":"The Rat Brain in Stereotaxic Coordinates","article-title":"Compact","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.bbr.2016.08.005_bib0150","first-page":"1","article-title":"Measurement of oxygen radicals and lipid peroxidation in neural tissues","volume":"17","author":"Hall","year":"2009","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.005_bib0155","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/BF02245655","article-title":"Reversal of antidepressant action by dopamine antagonists in an animal model of depression","volume":"104","author":"Sampson","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.005_bib0160","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1017\/S0954579401003029","article-title":"Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models","volume":"13","author":"Sanchez","year":"2001","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0165","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.pbb.2006.10.005","article-title":"Early deprivation increases exploration and locomotion in adult male Wistar offspring","volume":"85","author":"Marmendal","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.005_bib0170","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/NDT.S2450","article-title":"The development of behavioral and endocrine abnormalities in rats after repeated exposure to direct and indirect stress","volume":"4","author":"Daniels","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2016.08.005_bib0175","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF02247719","article-title":"Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline","volume":"109","author":"Muscat","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.005_bib0180","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s002130100701","article-title":"Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment","volume":"158","author":"Huot","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.005_bib0185","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/sj.npp.1301041","article-title":"Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression","volume":"31","author":"Jayatissa","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2016.08.005_bib0190","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0893-133X(97)00113-9","article-title":"Neurobiological similarities in depression and drug dependence: a self-medication hypothesis","volume":"18","author":"Markou","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2016.08.005_bib0195","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/bjp.2008.179","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex","volume":"154","author":"Geldof","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0200","first-page":"289","article-title":"Fluvoxamine in the treatment of anxiety disorders","volume":"1","author":"Irons","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbr.2016.08.005_bib0205","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2015.06.017","article-title":"Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration","volume":"1622","author":"Mabandla","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0210","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneumeth.2004.08.004","article-title":"Evaluation of animal models of Parkinson's disease for neuroprotective strategies","volume":"139","author":"Emborg","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2016.08.005_bib0215","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.005_bib0220","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0893-133X(00)00206-2","article-title":"Role of 5-HT2A and 5-HT2B\/2C receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors","volume":"24","author":"Mcmahon","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2016.08.005_bib0225","first-page":"609428","article-title":"Monoamine reuptake inhibitors in parkinson's disease","volume":"2015","author":"Huot","year":"2015","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.bbr.2016.08.005_bib0230","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1360-0443.2007.01770.x","article-title":"Interactions between methamphetamine and environmental stress: role of oxidative stress: glutamate and mitochondrial dysfunction","volume":"102","author":"Tata","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.bbr.2016.08.005_bib0235","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbr.2004.04.022","article-title":"Alterations in brain antioxidant status: protein oxidation and lipid peroxidation in response to different stress models","volume":"155","author":"\u015eahin","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0240","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2005.04.052","article-title":"Age-dependent effects of maternal deprivation on oxidative stress in infant rat brain","volume":"384","author":"Uysal","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2016.08.005_bib0245","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-230X-9-36","article-title":"Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue","volume":"9","author":"Dursun","year":"2009","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.bbr.2016.08.005_bib0250","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.pnpbp.2008.11.010","article-title":"Invivo antioxidant status: a putative target of antidepressant action","volume":"33","author":"Zafir","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2016.08.005_bib0255","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.psychres.2015.10.006","article-title":"Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder","volume":"230","author":"Chang","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.104.070961","article-title":"Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation","volume":"311","author":"Thomas","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2016.08.005_bib0265","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3109\/10715762.2012.683430","article-title":"Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress","volume":"46","author":"Kobuchi","year":"2012","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbr.2016.08.005_bib0270","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cellsig.2015.04.006","article-title":"Trazodone treatment protects neuronal-like cells from inflammatory insult by inhibiting NF-\u03baB, p38 and JNK","volume":"27","author":"Daniele","year":"2015","journal-title":"Cell. Signal."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816304971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816304971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T05:12:28Z","timestamp":1568351548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816304971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"alternative-id":["S0166432816304971"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.08.005","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}